Insiders Beam Therapeutics Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
21.26 ^USD	-5.68%		-8.08%	-21.90%

05-07	Beam Therapeutics Shares Fall After Q1 Revenue Misses Estimates	MT
05-07	Beam Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Beam Therapeutics Insider Sold Shares Worth $581,617, According to a Recent SEC Filing	04-04	MT
Beam Therapeutics Insider Sold Shares Worth $734,805, According to a Recent SEC Filing	04-04	MT
Beam CEO Andy Bromberg: Bitcoin ETFs a financialisation away from the original essence of crypto	01-30	MT
Beam Therapeutics Inc. Appoints Christi Shaw to Its Board of Directors	12-14	CI
Insider Sell: Beam Therapeutics	26/07/23	MT
Beam Therapeutics Appoints Gopi Shanker as Chief Scientific Officer	21/03/23	MT
Beam Therapeutics Inc. Appoints Gopi Shanker as Chief Scientific Officer	21/03/23	CI
Insider Sell: Beam Therapeutics	30/01/23	MT
Insider Sell: Beam Therapeutics	25/01/23	MT
Insider Sell: Beam Therapeutics	20/01/23	MT
Insider Sell: Beam Therapeutics	05/01/23	MT
Insider Sell: Beam Therapeutics	15/12/22	MT
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022	02/12/22	GL
Beam Therapeutics Named to Boston Globe’s Top Places to Work List for 2022	02/12/22	AQ
Insider Sell: Beam Therapeutics	02/11/22	MT
Beam Therapeutics Inc. Appoints John Lo as Chief Commercial Officer	09/08/22	CI
Insider Sell: Beam Therapeutics	29/07/22	MT
Beam Therapeutics Inc. Announces Executive Changes	09/05/22	CI
Insider Sell: Beam Therapeutics	03/05/22	MT
Beam Therapeutics Appoints John Maraganore, to Its Board of Directors	08/11/21	CI

No results for this search

Beam CEO Andy Bromberg: Bitcoin ETFs a financialisation away from the original essence of crypto

January 30, 2024 at 07:21 pm